Company / Capital Returned to Shareholders per Share
Johnson & Johnson Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$2.33
FY2025
5-year range
$0.91 / $2.33
FY2021-FY2025
Trend
+154.7%
vs FY2024
Sector context
#13 of 51
Health Care
What the data says
Johnson & Johnson's capital returned to shareholders per share of $2.33 is higher than 75% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders per Share returned to growth in FY2025 after 2 years of decline, reaching $2.33.
Based on SEC 10-K filings.
2.33 in FY2025 with a 5-year CAGR of +14.5%. Top quartile in the Health Care sector.
Improved from $1.89 to $2.33 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- -
Sector benchmark
-15.0% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 154.7% year-over-year.
- Ranks #13 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2016.
- Lowest capital returned to shareholders per share in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.33 | +154.7% |
| FY2024 | $0.91 | -51.7% |
| FY2023 | $1.89 | -16.4% |
| FY2022 | $2.26 | +75.5% |
| FY2021 | $1.29 | +9.1% |
| FY2020 | $1.18 | -52.0% |
| FY2019 | $2.46 | +16.8% |
| FY2018 | $2.10 | -6.9% |
| FY2017 | $2.26 | -27.9% |
| FY2016 | $3.14 | +70.5% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026